SINTEF Industry Process Technology
RESEARCH, TECHNOLOGY AND INNOVATION
SINTEF works closely with industry and academia with the aim of reducing and eliminating emissions, cutting costs, making industrial processes more green and sustainable. In addition, we focus on innovation and advanced production to create new industries and jobs. SINTEF can offer access to unique infrastructure and academic networks. We use our process technology expertise across the entire value chain from raw materials through processing to products to increase value creation in industry and solve tomorrow's challenges.
Multiphase Flow Laboratory
SINTEF Multiphase Flow Laboratory is one of the world's largest multiphase test facilities.
High Throughput laboratory - Oslo
The High Throughput laboratory can be divided in three main activates: 1) design and construction of high-throughput equipment, 2) parallel synthesis of materials, and 3) parallel screening of materials properties. We provide automated custom made high precisions equipment for a wide range of applications. Development and application of combinatorial and parallel approaches are used to accelerate the research and development of a large number of industrially relevant processes.
VirtuOSA - Virtual Surgery in the Upper Airways – New Solutions to Obstructive Sleep Apnea Treatment
The current project aims at enabling key technology for patient-specific diagnostics and treatment of Obstructive Sleep Apnea (OSA). When evaluating treatment options, clinicians are currently relying on general guidelines and personal experience, but they are lacking objective and predictive decision support tools. This project will provide required insight and software tools for computer-aided diagnostics and treatment of OSA through the promotion of Virtual surgery. Thereby, OSA patients can be treated more targeted, with reduced risk for the patient and reduced cost for society.
REALISE – Demonstrating a Refinery-Adapted Cluster-Integrated Strategy to Enable Full-Chain CCUS Implementation
REALISE will develop carbon capture, utilization and storage (CCUS) strategies for oil refineries-centered industrial clusters and demonstrate in a pilot scale an absorption technology based on novel solvent for cost-efficient and environmentally sustainable CO2 capture from multiple flue gas sources.
Study of the potential for reduced greenhouse gas emissions and the transition to a low-emission society through circular economy strategies
In this study SINTEF has focuses on circular economic opportunities that are expected to have a large potential for reducing the climate gas emissions associated with Norwegian consumption and production. Over a dozen circular strategies were selected and analysed as case studies with both the consumer perspective and the industry perspectives and their potential impact on reduction of green house gas emissions investigated. The study found that implementing the studied strategies could have a significant effect on reducing Norwegian greenhouse gas emissions, both within Norway and outside of Norway as Norwegian consumption is heavily dependent on global production and supply chains.
NV GL, TCM and SINTEF join forces in major international carbon capture and storage partnership
Three international organizations specializing in technology research, testing, advisory services, and standardization have joined forces to find new ways to accelerate the adoption of carbon capture, utilization and storage (CCUS) technology in emissions-heavy industries. DNV GL, SINTEF and Technology Centre Mongstad (TCM) have signed a memorandum of understanding to further develop carbon capture, utilization and storage technologies to make full-scale CCS a reality globally.
Ceramic 3D printing for fast, safe and cheaper production of vaccines
The NESSIE research project makes it possible for the first time to produce highly complex vaccines in large quantities at low cost using ceramic 3D printing. The novel process makes vaccines available to countries that previously could not afford the high cost of essential vaccines such as measles or rubella.